This is your
Golden
Moment
Want to fit more patients than ever before? With Biofinity®, you’re golden.
Be a hero to your patients – especially those who thought they could never wear contacts. Biofinity® XR toric and Biofinity® toric multifocal contact lenses are available in more than 238,000 unique prescriptions,1 which is more than 7x the options of all other monthly brands combined.2
These highly customized, made-to-order lenses are predominantly manufactured at CooperVision’s technologically advanced facility in Scottsville, N.Y. so most U.S. orders reach customers within a week.
Lens Technology
Aquaform® Technology
An innovative material technology that hydrates contact lenses to twice their weight in water for natural wettability and incredible comfort.4 The material retains water from core to surface without the need for surfacing coatings or wetting agents for proven comfort that lasts all day.4,5
Optimized Toric Lens Geometry™
A multifaceted toric lens design that provides excellent stability, predictable orientation and consistent vision performance.4 The uniform horizontal thickness provides excellent lens stability with minimal rotation for better visual acuity. In addition, the smooth, continuous ballast maximizes comfort during eyelid interaction.4
Balanced Progressive Technology®
This technology, incorporated in Biofinity® toric multifocal, has two different optical designs (D and N) to provide exceptional vision at all distances: near, intermediate and far —allowing for an individualized fitting for each wearer and eye.4 With the OptiExpert™ Contact Lens Calculator, the fitting process is simpler, and the app speeds up the contact lens selection.†6
Featured Videos
Connecting Through Care: Fitting Biofinity® XR toric and Biofinity® toric multifocal
Freeing Patients from Readers with Biofinity® toric multifocal
Expanding Contact Lens Options with Biofinity® toric multifocal and Biofinity® XR toric
“The faster, consistent Biofinity® toric multifocal delivery times have made a huge difference for our practice. We are able to schedule patients for follow-up appointments in a more timely fashion, and if we need to adjust the prescription, the patient isn't waiting weeks for new trials. As a result, we are prescribing the product much more frequently, and seeing great success with it.”
Aaron Stewart, OD
PersonalEYES Vision Care
Grand Rapids, MI
PersonalEYES Vision Care
Grand Rapids, MI
Product Details
| BASE CURVE (mm) |
DIA (mm) |
SPHERE POWER |
CYLINDER POWER |
AXIS | ADD POWER | |
|---|---|---|---|---|---|---|
Biofinity® XR toric |
8.7 | 14.5 | +8.50D to +20.00D and -10.50D to -20.00D (0.50D steps) | -0.75, -1.25, -1.75, -2.25 | 5° to 180° (5° steps) | -- |
| +20.00D to -20.00D (0.50D steps after +/-6.00D) | -2.75, -3.25, -3.75, -4.25, -4.75, -5.25, -5.75 | |||||
Biofinity® toric multifocal |
8.7 | 14.5 | +10.00D to -10.00D (0.50D steps after +/-6.00D) | -0.75 to -5.75 (0.50D steps) | 5° to 180° (5° steps) | +1.00 +1.50 +2.00 +2.50 |
* 51% of ECPs selected Biofinity® brand contact lenses vs. 12% for second ranked from the widely prescribed lens options provided; 4.3 times more than the next largest brand.
† Based on use with Biofinity® toric, MyDay® toric and clariti® 1 day toric lenses.
† Based on use with Biofinity® toric, MyDay® toric and clariti® 1 day toric lenses.
- CVI data on file, 2023. Based on total number of prescription option combinations (for sphere, cylinder, axis and add - including D & N combinations) manufactured.
- CVI data on file, 2025. Based on number of parameter options available in the USA across all competitive monthly replacement soft contact lenses from the 4 main manufacturers as reported by Tylers Quarterly June 2025.
- CVI data on file, 2025. US ECP Online Survey. N= 212 ECPs who fit Biofinity® family products.
- CVI data on file, 2024.
- CVI data on file, 2023; Based on global product sales and internal estimates of products using Aquaform® Technology over 12 months in 2023.
- Luensmann D et al. Toric lens fitting success supported by an online fitting App. Poster presented at NCC/BCLA 2020.